Dube Eric M
CIK 0001763494 Name as filed on the most recent filing
Filed as Dube Eric M (30)
45 transaction lines · from 30 filings · filed 2020-01-08 to 2026-05-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
45 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-06 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 22,500 disposed | 43.95 | 988,875.00 | Form 4, filing 0001763494-26-000006 | |
| 2026-04-15 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 56,815 disposed | 41.01 | 2,329,983.15 | Form 4, filing 0001763494-26-000005 | |
| 2026-04-15 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 7,165 disposed | 41.75 | 299,138.75 | Form 4, filing 0001763494-26-000005 | |
| 2026-04-15 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 20 disposed | 42.66 | 853.20 | Form 4, filing 0001763494-26-000005 | |
| 2026-04-01 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 34,902 disposed | 30.55 | 1,066,256.10 | Form 4, filing 0001763494-26-000004 | |
| 2026-04-01 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 25,098 disposed | 31.46 | 789,583.08 | Form 4, filing 0001763494-26-000004 | |
| 2026-02-20 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 60,000 disposed | 30.10 | 1,805,766.00 | Form 4, filing 0001763494-26-000003 | |
| 2026-02-03 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 66,452 disposed | 32.06 | 2,130,451.12 | Form 4, filing 0001763494-26-000002 | |
| 2026-02-03 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 33,635 disposed | 32.70 | 1,099,864.50 | Form 4, filing 0001763494-26-000002 | |
| 2026-01-27 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 51,865 disposed | 30.10 | 1,560,980.90 | Form 4, filing 0001763494-26-000001 | |
| 2026-01-23 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 8,135 disposed | 30.01 | 244,153.31 | Form 4, filing 0001763494-26-000001 | |
| 2025-10-29 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 27,128 disposed | 30.12 | 817,073.66 | Form 4, filing 0001763494-25-000005 | |
| 2025-10-28 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 92,872 disposed | 30.38 | 2,821,358.49 | Form 4, filing 0001763494-25-000005 | |
| 2025-05-05 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 18,924 disposed | 21.05 | 398,350.20 | Form 4, filing 0001415889-25-012058 | |
| 2025-02-11 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 11,375 disposed | 24.04 | 273,455.00 | Form 4, filing 0001415889-25-003820 | |
| 2025-02-03 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 50,691 disposed | 20.21 | 1,024,343.45 | Form 4, filing 0001415889-25-003065 | |
| 2025-01-22 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 10,736 disposed | 19.46 | 208,922.56 | Form 4, filing 0001415889-25-002006 | |
| 2024-09-09 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 21,125 disposed | 11.52 | 243,360.00 | Form 4, filing 0001415889-24-023094 | |
| 2024-02-01 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 10,016 disposed | 8.86 | 88,741.76 | Form 4, filing 0001415889-24-002285 | |
| 2024-02-01 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 9,106 disposed | 8.53 | 77,693.30 | Form 4, filing 0001415889-24-002285 | |
| 2024-01-23 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 7,873 disposed | 8.96 | 70,542.08 | Form 4, filing 0001415889-24-001799 | |
| 2023-09-05 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 4,455 disposed | 14.71 | 65,533.05 | Form 4, filing 0001209191-23-048255 | |
| 2023-02-01 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 8,196 disposed | 22.25 | 182,361.00 | Form 4, filing 0001209191-23-006417 | |
| 2023-01-24 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 6,442 disposed | 21.50 | 138,503.00 | Form 4, filing 0001209191-23-005034 | |
| 2023-01-05 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 5,625 disposed | 20.75 | 116,718.75 | Form 4, filing 0001209191-23-002327 | |
| 2022-02-10 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 4,832 disposed | 27.84 | 134,522.88 | Form 4, filing 0001209191-22-008818 | |
| 2022-01-31 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 4,813 disposed | 27.40 | 131,876.20 | Form 4, filing 0001209191-22-006357 | |
| 2022-01-24 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 7,873 disposed | 24.98 | 196,667.54 | Form 4, filing 0001209191-22-005078 | |
| 2022-01-05 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 10,361 disposed | 29.84 | 309,172.24 | Form 4, filing 0001209191-22-002156 | |
| 2022-01-05 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 2,139 disposed | 30.48 | 65,196.72 | Form 4, filing 0001209191-22-002156 | |
| 2022-01-04 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 4,832 disposed | 30.43 | 147,037.76 | Form 4, filing 0001209191-22-002156 | |
| 2021-08-17 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 7,836 disposed | 17.12 | 134,142.13 | Form 4, filing 0001209191-21-052084 | |
| 2021-06-02 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 4,780 disposed | 14.35 | 68,593.00 | Form 4, filing 0001209191-21-037615 | |
| 2021-06-01 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 4,782 disposed | 14.89 | 71,203.98 | Form 4, filing 0001209191-21-037615 | |
| 2021-02-08 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 4,813 disposed | 31.58 | 151,994.54 | Form 4, filing 0001209191-21-008795 | |
| 2021-02-05 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 4,813 disposed | 31.41 | 151,176.33 | Form 4, filing 0001209191-21-008795 | |
| 2021-02-03 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 2,406 disposed | 28.91 | 69,557.46 | Form 4, filing 0001209191-21-007631 | |
| 2021-02-02 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 6,328 disposed | 29.60 | 187,282.22 | Form 4, filing 0001209191-21-007025 | |
| 2021-02-02 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 2,406 disposed | 30.75 | 73,984.50 | Form 4, filing 0001209191-21-007025 | |
| 2021-01-06 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 3,438 disposed | 27.01 | 92,860.38 | Form 4, filing 0001209191-21-002592 | |
| 2021-01-05 |
Travere Therapeutics, Inc. TVTX |
S, Open-market sale | 3,438 disposed | 26.65 | 91,622.70 | Form 4, filing 0001209191-21-002592 | |
| 2020-09-21 |
Retrophin, Inc. RTRX |
S, Open-market sale | 9,240 disposed | 19.28 | 178,133.34 | Form 4, filing 0001209191-20-051611 | |
| 2020-09-21 |
Retrophin, Inc. RTRX |
S, Open-market sale | 1,565 disposed | 19.29 | 30,186.03 | Form 4, filing 0001209191-20-051611 | |
| 2020-01-08 |
Retrophin, Inc. RTRX |
S, Open-market sale | 3,750 disposed | 15.14 | 56,775.00 | Form 4, filing 0001209191-20-002631 | |
| 2020-01-07 |
Retrophin, Inc. RTRX |
S, Open-market sale | 3,750 disposed | 13.94 | 52,275.00 | Form 4, filing 0001209191-20-002631 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 45
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Dube Eric M, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001763494
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6